Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Addition Therapeutics develops RNA-only therapeutics using PRINT technology for genetic medicine.
Rumi.ai is an AI meeting assistant that transforms team conversations into searchable, shared knowledge.
Zoetis is an animal health company that advances care for animals and supports their health and wellbeing.
Digital Humans, Immersive learning & training
Attivare Therapeutics is a biotechnology company that develops small-molecule therapies that modulate immune and inflammatory pathways.
Embry Tech helps consumer brands unlock new verticals in wellness market through a patent-pending platform that includes wearable sensors.
The Way Out is breaking the cycle of incarceration through technology and living wage jobs.
BioSapien is a biotech startup that provides a drug delivery platform to deliver drugs for cancer treatment.
Molecular Loop is a biotechnology company that specializes in DNA sequencing.
Cork offers collateralized swaps against any pegged asset.
one.bio is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications.
The future of restaurant intelligence.
Zcooly offers several educational games for children.
AI powered collaboration platform
MeanFi provides a service that automates payment and banking workflows and allows for flexible payment schedules.
Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors.
Elarex is a Canadian healthcare technology company.
Particles for Humanity is a healthcare company transforming early-stage technologies into products.
Root Protocol integrates an intent-centric aggregator of digital identities, virtual accounts, social graphs and other components.
Aptoide, an independent Android app store that allows developers, OEM, telcos, and integrators to create and manage their own Android store.
Data aggregation and insight platform
A health-tech company creating a state-of-the-art innovation, called Robin the Robot.
Detact holds the patent for a new, innovative, real-time, bacterial detection system that enables hospital staff.
Zelira Hope 1 is owned by Zelira Therapeutics, that focuses on advancing the company's lead cannabinoid-based drug candidate.
Gate has invested in 1,189 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Gate's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Life Science, Enterprise Software. The firm invests across 45 different industry categories.
Among tracked funding rounds, Zoetis received $1.8B in a Post-IPO Debt round. Gate's total known invested capital is $507.3M.
Gate's average investment size is $7.2M across its portfolio of 1,189 companies.
Recent Gate portfolio additions include Addition Therapeutics, Rumi.ai, Zoetis, UneeQ, Attivare Therapeutics. These companies were founded in 2020 or later.